Printer Friendly

Browse Psoriasis topic

Articles

1-300 out of 600 article(s) nextnext page
Title Author Type Date Words
Improving diagnosis and treatment for the quantified patient. Jul 16, 2019 383
China Medical System Holdings Ltd. (0867. HK) Strategically Introduces Overseas Launched Blockbuster Innovative Products. Jul 16, 2019 2190
Diisostearyl Fumarate Market Exhibits Higher Growth Prospects during 2018-2028. Jul 9, 2019 809
Diisostearyl Fumarate Market Exhibits Higher Growth Prospects during 2018-2028. Jul 9, 2019 795
Diisostearyl Fumarate Market Exhibits Higher Growth Prospects during 2018-2028. Jul 8, 2019 795
Inflammatory Skin Diseases Treatment Market Growth and Sales Forecast 2018- 2026. Jul 2, 2019 785
Inflammatory Skin Diseases Treatment Market Growth and Sales Forecast 2018- 2026. Jul 2, 2019 770
Inflammatory Skin Diseases Treatment Market Size, Status and Forecast to 2026. Jul 2, 2019 770
Canada : Bausch Health Announces U.S. Launch of DUOBRII Lotion 0.01%/0.045% for Plaque Psoriasis in Adults. Jul 1, 2019 676
Autoimmune Diseases Take a Toll on Far More Women Than Men: Conditions that stem from abnormal immune system functioning may be related to the X chromosome. Jul 1, 2019 1040
Swaziland : Novartis highlights new publication showing IL-17A antibody Cosentyx improves inflammation and rapidly suppresses IL-23 in plaque psoriasis. Jun 29, 2019 447
Luxembourg,Spain : Spain: Investment Plan for Europe: EIB finances Almiralls research into new skin disease treatments. Jun 27, 2019 479
Cost-Effectiveness Analysis of Psoriasis Treatment Modalities in Malaysia. Azizam, Nor Azmaniza; Ismail, Aniza; Sulong, Saperi; Nor, Norazirah Md Jun 25, 2019 7215
Bristol-Myers Squibb to Divest Otzela in Face of US FTC Concerns Over Celgene Tie-Up. Jun 25, 2019 554
Bristol-Myers Squibb to Divest Otzela in Face of US FTC Concerns Over Celgene Tie-Up. Jun 25, 2019 584
Deal snapshot: BRISTOL-MYERS SQUIBB TO DIVEST OTZELA IN FACE OF US FTC CONCERNS OVER CELGENE TIE-UP. Jun 25, 2019 160
Celgene pushback surprising, but deal should still close, says Cantor Fitzgerald. Jun 24, 2019 142
Psoriasis is not contagious. Jun 20, 2019 848
Janssen Presents New Real-World Evidence Which Suggests that Effective PsA Treatment Should Target More than Skin and Joints. Jun 17, 2019 860
Nationwide campaign on psoriasis launched. Jun 16, 2019 195
Diisostearyl Fumarate Market Forecast Covering Growth Inclinations & Development Strategies until 20. Jun 14, 2019 795
Eli Lilly to present findings from SPIRIT-H2H study at EULAR. Clinical report Jun 14, 2019 348
Diisostearyl Fumarate Market Forecast Covering Growth Inclinations & Development Strategies until 20. Jun 13, 2019 795
Diisostearyl Fumarate Market Forecast Covering Growth Inclinations & Development Strategies until 20. Jun 13, 2019 809
Novartis Notes Strong Two-Year Response In Future 5 Cosentyx Trial. Jun 12, 2019 297
Novartis says Phase IIIb MAXIMISE trial met primary, key secondary endpoints. Jun 12, 2019 200
Taiwan Province of China : Athenex and PharmaEssentia Announce Positive Early Signals of Clinical Activity of KX2-391 (INN: tirbanibulin) in Patients with Psoriasis. Jun 12, 2019 400
Athenex, PharmaEssentia announce clinical activity signals in KX2-391 study. Jun 6, 2019 215
Inflammatory Skin Diseases Treatment Market Portrays High-End Demand across Major Geographies during. Jun 4, 2019 786
Inflammatory Skin Diseases Treatment Market Portrays High-End Demand across Major Geographies during. Jun 4, 2019 772
Inflammatory Skin Diseases Treatment Market Portrays High-End Demand across Major Geographies during. Jun 4, 2019 772
Proinflammatory diet may not trigger psoriasis, PsA, or AD. Pivovarov, Jill D. Jun 1, 2019 583
Positive PsA screens occur often in psoriasis patients. Karon, Amy Jun 1, 2019 486
Systemic Mycoses: An Overview for Natural Health Professionals. Thiel, Robert Disease/Disorder overview Jun 1, 2019 8227
Recurrent uveitis under golimumab treatment in a patient diagnosed with axial spondyloarthritis: Is it a paradoxical effect? Mengi, Alper; Ozdolap, Senay; Oray, Hande; Sarikaya, Selda Jun 1, 2019 1516
Make the Diagnosis. Jun 1, 2019 104
Canada : B.C. expands use of biosimilars to offer coverage for more treatment options. May 30, 2019 798
Beach Towels Market Expected to Secure Notable Revenue Share during 2018-2027. May 26, 2019 1181
Beach Towels Market Expected to Secure Notable Revenue Share during 2018-2027. May 24, 2019 1196
Beach Towels Market Synopsis, Demand, and Opportunity Forecast through 2027. May 24, 2019 1181
Mayne Pharma awarded FDA approval for SORILUX for treating adolescent plaque psoriasis. May 23, 2019 229
Mayne Pharma awarded FDA approval for SORILUX for treating adolescent plaque psoriasis. May 23, 2019 225
US Food and Drug Administration approves Mayne Pharma Group's SORILUX (calcipotriene) Foam. May 23, 2019 187
US Food and Drug Administration approves Mayne Pharma Group's SORILUX (calcipotriene) Foam. May 23, 2019 183
Phototherapy Equipment Market Share, Growth Analysis & Trends Forecasted during 2016 -- 2024. Report May 22, 2019 910
Phototherapy Equipment Market Share, Growth Analysis & Trends Forecasted during 2016 -- 2024. May 22, 2019 988
Phototherapy Equipment Market Share, Growth Analysis & Trends Forecasted during 2016 -- 2024. May 22, 2019 975
Sienna Biopharmaceuticals announces biopsy data from Phase 2b SNA-120 trial. May 14, 2019 193
Abbvie (NYSE: ABBV) - European Commission Approves SKYRIZI[TM] (risankizumab) for the Treatment of Moderate to Severe Plaque Psoriasis -- 30/4/2019. May 6, 2019 773
Survey highlights use of CAMs in psoriasis patients. Pivovarov, Jill D. May 1, 2019 559
Herpes zoster risk increased with some psoriasis, PsA treatments. Nogrady, Bianca May 1, 2019 469
AFib, CVD risks similar with ustekinumab and TNF blockers. Bowser, Andrew D. May 1, 2019 438
ASSOCIATION OF PSORIASIS AND SERUM URIC ACID LEVELS: A CASE CONTROL STUDY. Apr 30, 2019 2951
Abbvie (NYSE: ABBV) - AbbVie Expands Immunology Portfolio in the U.S. with FDA Approval of SKYRIZI[TM] (risankizumab-rzaa) for Moderate to Severe Plaque Psoriasis -- 23/4/2019. Apr 29, 2019 851
Bausch Health Companies Inc wins US FDA approval for DUOBRII Lotion 0.01%/0.045% for treating plaque psoriasis in adults. Apr 26, 2019 251
Bausch Health Companies Inc wins US FDA approval for DUOBRII Lotion 0.01%/0.045% for treating plaque psoriasis in adults. Apr 26, 2019 247
Psoriasis, poetry and managing the illness. Apr 26, 2019 883
Eli Lilly succeeds in phase three Taltz trial. Apr 25, 2019 223
Eli Lilly succeeds in phase three Taltz trial. Apr 25, 2019 219
Bausch Health announces FDA approval of Duobrii for plaque psoriasis. Apr 25, 2019 122
The skin conditions that can make life miserable; Chronic skin conditions can play havoc with people's work and social lives, sleep patterns and self-esteem. Here, consultant dermatologist Dr Avad Mughal highlights the most common skin concerns and how they can be treated... Apr 24, 2019 1215
AbbVie wins US FDA clearance for SKYRIZI to treart moderate to severe plaque psoriasis in adults. Apr 24, 2019 299
AbbVie wins US FDA clearance for SKYRIZI to treart moderate to severe plaque psoriasis in adults. Apr 24, 2019 295
AbbVie says FDA approves SKYRIZI. Apr 23, 2019 165
Global Psoriasis Market Analysis Covering Size, Share, Growth, Trends and Upcoming Opportunities by. Report Apr 23, 2019 697
Global Psoriasis Market Analysis Covering Size, Share, Growth, Trends and Upcoming Opportunities by. Report Apr 22, 2019 800
The skin conditions that can make life miserable; Chronic skin conditions can play havoc with people's work and social lives, sleep patterns and self-esteem. Here, consultant dermatologist Dr Avad Mughal highlights the most common skin concerns and how they can be treated... Apr 22, 2019 1215
Global Psoriasis Market Analysis Covering Size, Share, Growth, Trends and Upcoming Opportunities by. Report Apr 22, 2019 787
A Brighter future for psoriasis patients in Egypt. Apr 15, 2019 995
Know Upcoming Future Growth for Dermatology Devices Market Growth, Segments, Industry Analysis & Out. Apr 15, 2019 680
Global Inflammatory Skin Diseases Treatment Market Portrays High-End Demand across Major Geographies. Apr 15, 2019 776
Global Inflammatory Skin Diseases Treatment Market Portrays High-End Demand across Major Geographies. Apr 15, 2019 790
Psoriasis warrior Aby Marano continues to inspire, proudly shows off patches. Apr 12, 2019 306
NHS approve three new medicines. Apr 9, 2019 110
Common skin conditions and how to spot them; Consultant dermatologist Dr Juber Hafiji tells LIZ CONNOR how to spot if your rash is contact dermatitis, eczema, psoriasis or hives. Apr 3, 2019 891
Inflammatory Skin Diseases Treatment Market Drivers, Restraints, Opportunities, and Threats 2018-202. Apr 2, 2019 943
Inflammatory Skin Diseases Treatment Market Segmentation, Industry trends and Development to 2026. Apr 2, 2019 917
Novartis announces Chinese approval of Cosentyx for psoriasis patients. Apr 2, 2019 105
Framework Agreement On Climate Treatment For Psoriasis Patients. Apr 2, 2019 322
Joint psoriasis guidelines address biologics, comorbidities. Craven, Jeff Apr 1, 2019 839
Biologics curb coronary artery plaques in severe psoriasis. Splete, Heidi Apr 1, 2019 407
Dealing with psoriasis. Mar 31, 2019 1013
Japanese authorities approve AbbVie's SKYRIZI. Mar 28, 2019 183
Japanese authorities approve AbbVie's SKYRIZI. Mar 28, 2019 179
Sea Buckthorn Soothes Psoriasis. Wolfe, Sarah Clinical report Mar 27, 2019 670
AbbVie passes MHLW approval for SKYRIZI for the treatment of psoriasis in Japan. Mar 26, 2019 297
AbbVie passes MHLW approval for SKYRIZI for the treatment of psoriasis in Japan. Mar 26, 2019 293
AbbVie receives approval for SKYRIZI in Japan. Mar 26, 2019 124
Sanofi Starts Phase I Clinical Trials with SAR441169 Candidate Treatment for Psoriasis, Triggering Milestone Payment to Lead Pharma. Mar 22, 2019 497
Lead Pharma triggers fourth milestone payment under its license & collaboration agreement with Sanofi. Mar 21, 2019 234
Durect doses first patients in Phase 2a trial of plaque psoriasis candidate. Mar 21, 2019 120
Common skin conditions and how to spot them; Consultant dermatologist Dr Juber Hafiji tells LIZ CONNOR how to spot if your rash is contact dermatitis, eczema, psoriasis or hives. Mar 16, 2019 883
Common skin conditions and how to spot them; Consultant dermatologist Dr Juber Hafiji tells LIZ CONNOR how to spot if your rash is contact dermatitis, eczema, psoriasis or hives. Mar 16, 2019 857
Common skin conditions and how to spot them; Consultant dermatologist Dr Juber Hafiji tells LIZ CONNOR how to spot if your rash is contact dermatitis, eczema, psoriasis or hives. Mar 13, 2019 876
Common skin conditions and how to spot them; Consultant dermatologist Dr Juber Hafiji tells LIZ CONNOR how to spot if your rash is contact dermatitis, eczema, psoriasis or hives. Mar 13, 2019 891
Common skin conditions and how to spot them; Consultant dermatologist Dr Juber Hafiji tells LIZ CONNOR how to spot if your rash is contact dermatitis, eczema, psoriasis or hives. Mar 13, 2019 891
Common skin conditions and how to spot them; Consultant dermatologist Dr Juber Hafiji tells LIZ CONNOR how to spot if your rash is contact dermatitis, eczema, psoriasis or hives. Mar 13, 2019 883
Switzerland : Novartis Cosentyx shows superior improvements in psoriasis patients' quality of life versus Janssen's IL-23 Stelara. Mar 11, 2019 170
Switzerland : Novartis data confirm rapid response and high efficacy of Cosentyx in psoriasis patients for first time in China. Mar 11, 2019 247
Boehringer Ingelheim Says Novel Antibody Shows Potential to Transform Treatment of Rare Form of Psoriasis. Mar 8, 2019 617
Novartis reveals new data from Phase III Cosentyx study. Mar 6, 2019 207
Novartis reveals new data from Phase III Cosentyx study. Mar 6, 2019 203
Diet & health. Mar 4, 2019 875
Abbvie (NYSE: ABBV) - AbbVie Receives CHMP Positive Opinion for Risankizumab (SKYRIZI[TM]) for the Treatment of Moderate to Severe Plaque Psoriasis -- 1/3/2019. Mar 4, 2019 352
United States : AbbVie Receives CHMP Positive Opinion for Risankizumab (SKYRIZI) for the Treatment of Moderate to Severe Plaque Psoriasis. Mar 4, 2019 350
United States : AbbVie to Showcase Scientific Innovation and Research Advancements Across Dermatology Portfolio at 2019 AAD Annual Meeting. Mar 4, 2019 314
UCB presents positive data from Phase 2b BE ABLE extension study of bimekizumab. Mar 3, 2019 297
Mums are praising Child's Farm moisturiser for 'miraculous' effect on skin; Childs Farm's baby moisturiser is a big hit with parents. Mar 2, 2019 1605
AbbVie receives CHMP positive opinion for SKYRIZI. Mar 1, 2019 196
UCB to present data from immuno-dermatology portfolio at AAD. Mar 1, 2019 248
Tuberculin test conversion in patients with chronic inflammatory arthritis receiving biological therapy. Cerda, Osvaldo Luis; Correa, Maria De Los Angeles; Granel, Amelia; Marcos, Ana Ines; Giraldo, Claudi Report Mar 1, 2019 3475
Combining secukinumab and apremilast to successfully treat refractory psoriatic skin and joint disease: A novel approach. Nisar, Muhammad K. Letter to the editor Mar 1, 2019 934
Defining the criteria for early detection. Zoler, Mitchel L. Mar 1, 2019 2632
Study links psoriasis treatment and improvement in heart artery disease. Mar 1, 2019 289
The Janssen Pharmaceutical Companies of Johnson & Johnson wins US FDA's approval for TREMFYA for treating plaque psoriasis. Feb 28, 2019 303
The Janssen Pharmaceutical Companies of Johnson & Johnson wins US FDA's approval for TREMFYA for treating plaque psoriasis. Feb 28, 2019 299
Overcoming hurdles. Feb 22, 2019 485
Aby Marano upbeat despite autoimmune disease diagnosis. Feb 21, 2019 360
Australia : Mayne Pharma Launches Lexette (Halobetasol Propionate) Foam 0.05% in the United States. Feb 16, 2019 257
Mayne Pharma unveils Lexette (halobetasol propionate) foam 0.05% in the US plaque psoriasis market. Feb 14, 2019 206
Kim Kardashian Shares Psoriasis Treatment Photos. Feb 12, 2019 343
Why are my joints sore? DR MIRIAM STOPPARD; Helping to keep you fit and healthy. Feb 12, 2019 265
Call to publish psoriasis data. Feb 10, 2019 515
Kim Kardashian Has Psoriasis: Causes, Symptoms And Treatment. Feb 6, 2019 380
Chronic infections cause unique problems in psoriasis. Lesney, Mark S. Feb 1, 2019 436
Algorithm addresses TNF inhibitor-induced psoriasis. Craven, Jeff Drug overview Feb 1, 2019 744
Psoriasis battle inspired cosmetics business; Sara Cheeney runs Pure Perfection... and battled cancer while getting her business off the ground. Jan 30, 2019 989
Australia : Medicines for the treatment of psoriasis listed on the PBS. Jan 28, 2019 497
The Effect of Aloe Vera Clinical Trials on Prevention and Healing of Skin Wound: A Systematic Review. Hekmatpou, Davood; Mehrabi, Fatemeh; Rahzani, Kobra; Aminiyan, Atefeh Report Jan 1, 2019 6042
ACR, NPF unveil new PsA treatment guideline. Brunk, Doug Jan 1, 2019 755
Association of dyslipidemia with psoriasis. Dec 31, 2018 3472
EFFECTIVENESS OF CALCIPOTRIOL VERSUS BETAMETHASONE DIPROPIONATE IN THE TREATMENT OF MILD TO MODERATE CHRONIC PLAQUE PSORIASIS. Report Dec 31, 2018 1415
Eli Lilly announces Taltz meets primary, secondary endpoints in SPIRIT-H2H study. Clinical report Dec 17, 2018 230
New Phase 3 Data Demonstrate Superiority of Tremfya vs Cosentyx in Delivering PASI 90 Responses in the Treatment of Moderate to Severe Plaque Psoriasis at Week 48. Clinical report Dec 17, 2018 139
Janssen Pharmaceutical's psoriasis drug achieves primary endpoint in phase 3 trial. Dec 14, 2018 173
Janssen Pharmaceutical's psoriasis drug achieves primary endpoint in phase 3 trial. Dec 14, 2018 169
Janssen says Phase 3 data demonstrate superiority of Tremfya vs. Consentyx. Clinical report Dec 12, 2018 151
Global Dermatological Products Market to Experience Significant Growth during the Forecast Period 20. Dec 11, 2018 1082
Global Dermatological Products Market to Experience Significant Growth during the Forecast Period 20. Dec 11, 2018 1104
Global Dermatological Products Market to Experience Significant Growth during the Forecast Period 20. Dec 11, 2018 1117
Preparations For The Treatment Of Ra, Psoriasis, Csu Ii. Dec 6, 2018 116
Preparations For The Treatment Of Ra, Psoriasis, Csu I. Dec 5, 2018 119
Psoriasis adds to increased risk of cardiovascular procedures, surgery in patients with hypertension. Craven, Jeff Dec 1, 2018 495
No evidence of subclinical axial involvement in skin psoriasis. Nogrady, Bianca Dec 1, 2018 445
Encore Dermatology Releases Phase 2 Safety Data Demonstrating Lower Systemic Drug Exposure with Impoyz Cream, 0.025% Compared to Temovate Cream, 0.05%. Nov 29, 2018 330
Ways to keep psoriasis under control. Nov 22, 2018 678
Psoriasis can put you at type 2 diabetes risk. Nov 20, 2018 377
TYK2 INHIBITOR: Novel oral agent shows unprecedented efficacy in psoriasis. Jancin, Bruce Nov 1, 2018 966
Flu vaccination lags among patients with psoriasis. Kling, Jim Nov 1, 2018 454
Anti-TNF agents preferred for severe disease in pregnancy. Haelle, Tara Nov 1, 2018 777
Adalimumab safety update finds no new signals. Palmer, Christopher Brief article Nov 1, 2018 299
US FDA grants approval to Sandoz's Hyrimoz. Nov 1, 2018 136
US FDA grants approval to Sandoz's Hyrimoz. Nov 1, 2018 132
Global TNF Inhibitors Market Projected to Grow at a CAGR of 2.54% during 2018- 2026. Nov 1, 2018 748
Global TNF Inhibitors Market Projected to Grow at a CAGR of 2.54% during 2018- 2026. Report Nov 1, 2018 718
Global TNF Inhibitors Market Projected to Grow at a CAGR of 2.54% during 2018- 2026. Nov 1, 2018 762
Psoriasis adds to increased risks in hypertension. Craven, Jeff Nov 1, 2018 627
Novartis' Sandoz announces FDA approval for biosimilar Hyrimoz. Oct 31, 2018 103
World Psoriasis Day being observed today. Oct 30, 2018 240
World Psoriasis Day being observed today. Oct 30, 2018 285
'World Psoriasis Day' to be observed in RMI on Oct 29. Oct 29, 2018 203
Customer pointed at psoriasis.. then told me: I thought you had to be pretty to work here. Oct 29, 2018 471
Dermatologists emphasise impact of psoriasis on everyday life. Oct 29, 2018 420
Dubai sets Guinness record for 'largest awareness ribbon'. Oct 29, 2018 320
5,000 people in Pakistan suffer from Psoriasis. Oct 29, 2018 414
World Psoriasis Day! Oct 29, 2018 236
'World Psoriasis Day' to be observed in RMI. Oct 29, 2018 205
Dermatologists ring alarm over psoriasis. Oct 28, 2018 728
Monday, October 29, 2018. Oct 28, 2018 245
More than 125m people worldwide suffering from Psoriasis. Oct 27, 2018 526
United States : Celgene Launches Campaign to Encourage Others to Look Beyond the Surface of the Condition. Oct 27, 2018 726
Psoriasis disturbs patient's life badly. Oct 25, 2018 418
More than 125 million people worldwide affected by Psoriasis: PPF report. Oct 25, 2018 439
New Three-Year Data for Tremfya Demonstrates Well Maintained Rates of Skin Clearance in Patients with Moderate to Severe Plaque Psoriasis, According to Janssen. Clinical report Oct 23, 2018 455
United States : Amgen Launches AMGEVITA (Biosimilar Adalimumab) In Markets Across Europe. Oct 20, 2018 437
Philippines : Understand people with psoriasis. Oct 19, 2018 221
Biogen launches adalimumab biosimilar, referencing Humira(R), in the Europan Union. Oct 18, 2018 155
Biogen launches adalimumab biosimilar, referencing Humira(R), in the Europan Union. Oct 18, 2018 151
Hypertensive patients with Psoriasis more likely to require cardiovascular procedures. Oct 17, 2018 183
Amgen launches Amgevita in markets across Europe. Oct 16, 2018 106
A CLINICO-AETIOLOGICAL STUDY OF CASES OF ERYTHRODERMA ATTENDING TERTIARY CARE HOSPITAL IN NORTH-EAST INDIA. Boruah, Jahnabi; Gupta, Bhaskar Report Oct 15, 2018 1830
Over 2 million Filipinos diagnosed with Psoriasis. Oct 14, 2018 292
United States : Celgene Announces Phase 3 STYLE Study of OTEZLA in Moderate to Severe Scalp Psoriasis Met Primary Endpoint. Oct 11, 2018 262
Bausch Health Companies Inc announces tentative US FDA NDA approval for BRYHALI Lotion, 0.01% to treat plaque psoriasis. Oct 9, 2018 303
Bausch Health Companies Inc announces tentative US FDA NDA approval for BRYHALI Lotion, 0.01% to treat plaque psoriasis. Oct 9, 2018 299
Psoriasis: a burden for life. Oct 7, 2018 345
Biological solutions to skin conditions. Oct 7, 2018 379
AbbVie scripts for Humira relatively weak in Q3, says Piper Jaffray. Oct 2, 2018 119
Strata Skin Sciences announces completion of MMD accessory trial. Oct 1, 2018 250
Assess a vesiculopustular lesion in three steps. Brunk, Doug Oct 1, 2018 301
Psoriasis and Psoriatic Arthritis. Armstrong, April W.; Menter, Alan Oct 1, 2018 556
Is PASI 100 the new benchmark in psoriasis? Jancin, Bruce Oct 1, 2018 1179
Family history of psoriasis and PsA predicts disease phenotype. Andrews, Nick Oct 1, 2018 566
Make a PEST of your psoriasis patients. Jancin, Bruce Oct 1, 2018 619
Elderly patients with psoriasis can benefit from biologies with low rates of adverse events. Sullivan, Michele G. Oct 1, 2018 922
Meta-analysis: Lifestyle changes improve psoriasis. Jancin, Bruce Oct 1, 2018 764
Online psoriasis consultations shown equivalent to office visits. Zoler, Mitchel L. Oct 1, 2018 541
Genital psoriasis is the worst: Patients sound off. Jancin, Bruce Oct 1, 2018 722
CV risk factors go undiagnosed, untreated in many psoriatic patients. Laubach, Lori Oct 1, 2018 552
Topical corticosteroid-retinoid combination effective in moderate to severe psoriasis. Nogrady, Bianca Oct 1, 2018 678
Psoriasis therapy with biologies not linked to increased cancer risk. Nellist, Catherine Cooper Oct 1, 2018 679
Psoriasis duration reflects cardiovascular event risk. Jancin, Bruce Oct 1, 2018 696
Biologics bring potential for long-term remission off treatment. Jancin, Bruce Clinical report Oct 1, 2018 962
Most PsA patients discontinue initial biologic within 12 months. Bowser, Andrew D. Oct 1, 2018 598
Medication app boosts psoriasis patients' short-term adherence. Splete, Heidi Oct 1, 2018 654
FDA approves certolizumab label update for pregnancy, breastfeeding. Laubach, Lori Oct 1, 2018 794
PPACMAN aims to advance the combined rheum-derm clinic approach. Mechcatie, Elizabeth Oct 1, 2018 313
Psychodermatology: a molecular link between psoriasis and anxiety disorder. Klimov, Eugene; Tretiakov, Artemii; Rudko, Olga; Soboleva, Anna; Danilin, Ivan; Korsunskaya, Irina; Report Oct 1, 2018 3782
Clinicopathologic retrospective analysis of annular pustular psoriasis. Owczarczyk-Saczonek, Agnieszka; Znajewska-Pander, Aleksandra; Owczarek, Witold; Maciejewska-Radomska Report Oct 1, 2018 3600
XBiotech announces EPO patent for bermekimab. Sep 26, 2018 235
MorphoSys says licensee has begun study to test gselkumab in pediatric group. Sep 25, 2018 132
What happens to psoriasis before and after Dove DermaSeries. Sep 17, 2018 722
Data on IL36R inhibitor positive for AnaptysBio, says Cantor Fitzgerald. Sep 17, 2018 114
Novartis real-world evidence confirms efficacy and safety benefits of Cosentyx. Clinical report Sep 13, 2018 140
AbbVie announces patient reported outcome data for Phase 3 study of Risankizumab. Sep 13, 2018 208
Janssen's Tremfya Improves Long-Term Patient-Reported Outcomes in Patients with Moderate to Severe Plaque Psoriasis. Sep 13, 2018 1034
Celgene says OTEZLA showed meaningful improvements in quality-of-life measures. Sep 12, 2018 458
Otezla Showed Meaningful Improvements in Clinical and Quality-of-Life Measures of Psoriasis Beyond Those Captured by Assessing Skin Alone. Disease/Disorder overview Sep 12, 2018 1179
Bristol-Myers Squibb Claims Novel, Oral, Selective TYK2 Inhibitor Delivered Significant Skin Clearance in Patients with Moderate to Severe Plaque Psoriasis in Phase 2 Trial. Sep 12, 2018 399
Bristol-Myers says efficacy endpoints achieved in Phase 2 study of BMS-986165. Sep 12, 2018 142
Eli Lilly initiates IXORA-R head-to-head clinical trial. Clinical report Sep 10, 2018 164
Effect of RNA Interference Targeting STAT3 Gene Combined with Ultrasonic Irradiation and SonoVue Microbubbles on Proliferation and Apoptosis in Keratinocytes of Psoriatic Lesions. Ran, Li-Wei; Wang, Hao; Lan, Dong; Jia, Hong-Xia; Yu, Si-Si Report Sep 5, 2018 5052
AbbVie to present new data across investigational medicines at EADV Congress. Sep 4, 2018 231
U.K. registry study provides more data on infliximab's infection risk. Kling, Jim Clinical report Sep 1, 2018 434
Extended data show ixekizumab efficacy maintained. Splete, Heidi Sep 1, 2018 348
Drug Induced Thrombotic Microangiopathy with Certolizumab Pegol. Baysal, Mehmet; Umit, Elif Gulsum; Saritas, Fatih; Kodal, Nil Su; Demir, Ahmet Muzaffer Case study Sep 1, 2018 1319
Relationship between human leukocyte antigen DRB1 and psoriasis in Iraqi patients. Zalzala, Haider H.; Abdullah, Galawish A.; Abbas, Mohammed Y.; Mohammedsalih, Hyam R.; Mahdi, Batool Sep 1, 2018 2711
FDA Accepts Resubmission of New Drug Application for Duobrii Lotion. Aug 30, 2018 179
Canada : FDA Accepts Resubmission Of New Drug Application For Duobrii1 (Halobetasol Propionate And Tazarotene) Lotion. Aug 30, 2018 187
Can-Fite BioPharma enrols and doses first patient in phase three Piclidenoson Comfort trial. Aug 23, 2018 165
Can-Fite BioPharma enrols and doses first patient in phase three Piclidenoson Comfort trial. Aug 23, 2018 161
China National Drug Administration Accepts Biologics License Application for Proposed Biosimilar to Humira. Aug 22, 2018 304
Canada,United States : Ortho Dermatologics Resubmits U.S. New Drug Application For DUOBRII (halobetasol propionate and tazarotene) Lotion. Aug 20, 2018 157
Ortho Dermatologics Resubmits US New Drug Application for DuobrII Lotion. Aug 17, 2018 235
Ortho Dermatologics resubmits DUOBRII's NDA with US FDA. Aug 16, 2018 173
Ortho Dermatologics resubmits DUOBRII's NDA with US FDA. Aug 16, 2018 169
Bausch Health division announces resubmission of NDA for Duobrii. Aug 15, 2018 142
Get the most from your primary care provider. Reprint Aug 8, 2018 745
A quest to cure psoriatic disease. Liao, By Wilson Reprint Aug 8, 2018 706
How does your diet affect psoriasis? Researchers offer takeaways for improving your overall health when it comes to diet and psoriasis. Reprint Aug 8, 2018 580
The calm after the storm In Hurricane Maria's aftermath, an uninsured woman fights her flares with support from the Patient Navigation Center. Reprint Aug 8, 2018 590
Did you know? Aug 8, 2018 183
Various things contribute to psoriasis flare-ups Flare-ups. Aug 8, 2018 597
Can-Fite Signs Development and Distribution Agreement for Piclidenoson and Namodenoson in China. Aug 8, 2018 601
Success is natural for this couple. Aug 7, 2018 434
FDA grants 510(k) clearance for Strata's Multi-Micro Dose Tip for XTRAC. Aug 6, 2018 200
Patient fears as vital skin ward faces closure; NHS CONFIRM DEPARTMENT UNDER REVIEW Sufferers hit out over lifeline hospital unit. Aug 5, 2018 634
Hydroxychloroquine-Induced Psoriasis-form Erythroderma in a Patient with Systemic Lupus Erythematosus. Wang, Wen-Ming; Wang, Kevin; Wang, Tao; Jin, Hong-Zhong; Fang, Kai Letter to the editor Aug 5, 2018 944
Elderly psoriasis patients have low event rate with biologics. Sullivan, Michele G. Aug 1, 2018 622
Adalimumab strikes out for aortic inflammation in psoriasis study. Otto, M. Alexander Aug 1, 2018 587
Sandoz receives European Commission approval for biosimilar Hyrimoz. Jul 27, 2018 133
Psoriasis disease. Jul 25, 2018 155
Sienna Biopharmaceuticals completes maximal use safety study of SNA-120. Jul 24, 2018 326
Spherix Quarterly Study Shows Growth in Use of Taltz in Psoriatic Arthritis While Use of Xeljanz Remains Flat. Jul 23, 2018 242
GSK confirms deal with Dermavent Sciences. Jul 13, 2018 159
GSK confirms deal with Dermavent Sciences. Jul 13, 2018 155
Aurigene doses first volunteer under Phase 1 INDUS trial of AUR-101. Jul 12, 2018 167
Aurigene doses first volunteer under Phase 1 INDUS trial of AUR-101. Jul 12, 2018 163
Mum told lesions on her forehead were psoriasis but doctors later revealed devastating cancer diagnosis; Self-confessed sun worshipper Margaret 'Mags' Murphy, 47, has opened up about her battle with skin cancer. Jul 7, 2018 676
CBC values linked to CVD risk in psoriasis. Otto, M. Alexander Jul 1, 2018 563
Titrate slowly to avoid apremilast-associated diarrhea. Jancin, Bruce Jul 1, 2018 1287
Acne and Rosacea. Harper, Julie C. Jul 1, 2018 374
Rosacea tied to physical and psychological comorbidities. Splete, Heidi Jul 1, 2018 750
HIGHLIGHTS OF Skin Disease Education Foundation's 42nd Annual Hawaii Dermatology Seminar[R] Grand Hyatt Kauai, Hawaii; February 4-9, 2018. Baldwin, Hilary E.; Gold, Linda F. Stein; Gordon, Kenneth B.; Green, Jeremy B.; Leonardi, Craig L.; Jul 1, 2018 11930
Cutaneous toxicity of oral low-dose methotrexate. Jalandhara, Priyanka; Kaeley, Gurjit Clinical report Jul 1, 2018 1710
Citocinas proinflamatorias, biomarcadores, genetica y sistema inmunologico: un enfoque mecanicista de la depresion y la psoriasis. Aleem, Daniyal; Tohid, Hassaan Jul 1, 2018 8239
Quality of life assessment in patients of psoriasis. Jun 30, 2018 3204
Lupin partners with Mylan to commercialise Enbrel (Etanercept) Biosimilar. Jun 28, 2018 185
Lupin partners with Mylan to commercialise Enbrel (Etanercept) Biosimilar. Jun 28, 2018 181
Mylan, Lupin partner to commercialize Enbrel biosimilar. Jun 28, 2018 141
Pfizer receives EU marketing authorization for XELJANZ. Jun 28, 2018 158
Ayurvedic nutrition advice. Jun 25, 2018 333
'It's infant psoriasis.. she's not contagious' MUM TELLS OF LITTLE MAISIE'S TORMENT; Parents hit back at rude strangers who accuse them of neglecting tot. Jun 22, 2018 385
Janssen's Tremfya receives 'positive' health technology assessments in Europe. Jun 13, 2018 329
FDA Clears First System to Combine Smartphone Controlled UVB Light with Occlusive Hydrating Gels to Treat Inflammatory Skin Disease. Jun 11, 2018 439
Switzerland : Sandoz receives positive CHMP opinion for proposed biosimilar adalimumab. Jun 5, 2018 329
Psoriasis included in PhilHealth coverage. Jun 3, 2018 261
HEALTHIEST MILKS... PSORIASIS... FRAILTY. Wanagat, Jonathan Jun 1, 2018 679
Online consultations shown equivalent to office visits. Zoler, Mitchel L. Jun 1, 2018 373
Topical tapinarof heads for phase 3 trials in atopic dermatitis and psoriasis. Jancin, Bruce Jun 1, 2018 660
Children with psoriasis face multitude of potential problems and comorbidities. Brunk, Doug Jun 1, 2018 1332
Adalimumab outperforms methotrexate reating severe pediatric plaque psoriasis. Nellist, Catherine Cooper Clinical report Jun 1, 2018 927
Topical tapinarof heads for phase 3 trials in atopic dermatitis and psoriasis. Jancin, Bruce Jun 1, 2018 660
Children with psoriasis face multitude opotential problems and comorbidities. Brunk, Doug Jun 1, 2018 1333
Adalimumab outperforms methotrexate in reating severe pediatric plaque psoriasis. Nellist, Catherine Cooper Clinical report Jun 1, 2018 929
Epithelioid myxofibrosarcoma developing at the injection site of Adalimumab therapy for psoriatic synovitis. Farshid, Gelareh; Prowse, Phoebe; True, Barbara Jun 1, 2018 1770
The Future is Now for Immunology Research: Building our understanding of disease pathology and exploring therapeutic combinations will usher in a new wave of treatment advances for patients living with immune-mediated diseases. Olson, Lisa Jun 1, 2018 969
Comorbidities newly associated with psoriasis: correlation versus causality. Porumb-Andrese, Elena; Vaja, Dan; Statescu, Laura; Grajdeanu, Alina; Patrascu, Adriana; Gheuca-Solov Report Jun 1, 2018 2074
FDA Approval of Cimzia (certolizumab pegol) Presents New Treatment Options for Plaque Psoriasis. May 31, 2018 282
Autoimmune and Molecular Insights into Skin Psoriasis and psoriatic Arthritis. Conference news May 31, 2018 1314
UCB awarded US FDA approval for CIMZIA (certolizumab pegol) to treat moderate-to-severe plaque psoriasis. May 30, 2018 294
UCB awarded US FDA approval for CIMZIA (certolizumab pegol) to treat moderate-to-severe plaque psoriasis. May 30, 2018 290
Gilead, Galapagos NV announce Phase 2 EQUATOR study meets primary endpoint. Clinical report May 30, 2018 182
Sandoz's Zessly receives approval from European Commission. May 28, 2018 151
Sandoz's Zessly receives approval from European Commission. May 28, 2018 147
Eli Lilly and Company wins US FDA approval for label update to include Taltz data in psoriasis involving the genital area. May 23, 2018 288
Eli Lilly and Company wins US FDA approval for label update to include Taltz data in psoriasis involving the genital area. May 23, 2018 284
Novartis to launch ARROW trial to assess mechanistic superiority of Cosentyx over Tremfya. May 15, 2018 227
Novartis to launch ARROW trial to assess mechanistic superiority of Cosentyx over Tremfya. May 15, 2018 223
NICE backs Janssen's Tremfya for NHS use. May 11, 2018 165

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters